Highlighting our unique insights across key growth sectors.
Equity Research Rewind highlights William Blair’s in-depth thematic research from the past few months. The inaugural edition includes extensive research covering 10 themes, including innovations in obesity treatment, challenges impacting growth in large pharma, evolving industry dynamics in the accounting services sector, the recovery in the furniture and home improvement market, and the state of generative AI.
President Donald Trump’s rapid structural changes are transforming the U.S. economy. This report by Richard de Chazal, CFA, highlights the shift from labor to capital investment, the transition to a supply-driven inflation regime, and the dominance of fiscal policy.
Explore the latest advancements in CAR-T therapies from William Blair’s Equity Research healthcare and biotechnology team. Discover how these next-generation therapies are transforming the treatment landscape for patients with liquid tumors.
Discover the latest insights in pharmaceutical outsourcing and services with our comprehensive analysis of FDA approvals for 2024. This report delves into the trends and key conclusions from a decade of data, highlighting the significant uptick in outsourcing penetration and the robust growth in biotech funding.
Driven by GenAI improvements, companies are seeing increased advertising performance, allowing ads to be more dynamic, personalized, and instantaneous. William Blair technology, media, and communications analyst Ralph Schackart sat down with an advertising industry participant to learn more.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
